期刊: 药物化学杂志
In the context of the coronavirus pandemic, Remdesivir has garnered significant attention due to its broad-spectrum antiviral activity. Developed by Gilead Sciences, this drug exhibits remarkable antiviral effects by inhibiting the virus's nsp12 polymerase, even in the presence of the virus's proofreading mechanism.
期刊:Cell Research
扫码关注公众号